BNT327-05 (ROSETTA Breast-01)

A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy versus placebo with chemotherapy in patients with previously untreated locally recurrent inoperable or metastatic TNBC whose tumor PD-L1 status is considered negative

Enquire

Trial overview

Clinical Area

Medical Oncology

Disease

Breast cancer

Disease site

Breast

Study Phase

III

Trial Identifiers

Registration number: NCT07173751

https://clinicaltrials.gov/study/NCT07173751

GenesisCare Location(s)

South Terrace (Medical Oncology & Haematology)

St Andrew’s Medical Centre, Level 1, 321 South Terrace, Adelaide, SA, 5000, Australia

08 8463 2500

reception@aoah.com.au

Find out more Get directions

Principal Investigator(s)

Medical Oncologist

A/Prof Nick Murray

BM MS MA DPhil FRCP(Lon) FRACP

View Profile

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.

First name *

Last name *

Email *

Phone *

State *

Postcode *

What is the reason for enquiry?

How would you prefer to be contacted? *

Phone

By submitting you acknowledge we will use the information you are providing to contact you about your enquiry. For more information about how we handle your personal information, please refer to the GenesisCare Privacy Policy.

Disclaimer:

This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.

Disclaimer: